Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 76,950 shares at $78.42 ($6.4M) on 2025-06-02, disclosed to the SEC on 2025-06-04.
Scheduled sale ($6.4M) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $78.42 | 4,881 | $383K | 6.0% |
| 2 | $78.42 | 4,881 | $383K | 6.0% |
| 3 | $79.48 | 3,050 | $242K | 3.8% |
| 4 | $80.30 | 2,988 | $240K | 3.8% |
| 5 | $80.30 | 2,988 | $240K | 3.8% |
| 6 | $81.33 | 1,820 |
| $148K |
| 2.3% |
| 7 | $81.33 | 1,820 | $148K | 2.3% |
| 8 | $82.26 | 1,263 | $104K | 1.6% |
| 9 | $82.26 | 1,263 | $104K | 1.6% |
| 10 | $83.46 | 4,631 | $387K | 6.1% |
| 11 | $83.46 | 4,631 | $387K | 6.1% |
| 12 | $84.57 | 12,959 | $1.1M | 17.2% |
| 13 | $84.57 | 12,959 | $1.1M | 17.2% |
| 14 | $85.01 | 8,408 | $715K | 11.2% |
| 15 | $85.01 | 8,408 | $715K | 11.2% |
| Total | $82.99 avg | 76,950 | $6.4M | 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |